QT Vascular launches pivotal trial for drug-coated peripheral balloon

QT Vascular said today that it launched the U.S. pivotal trial for its Chocolate Touch drug-coated peripheral balloon in the hopes of winning FDA approval. The device won CE Mark clearance in September 2015.
The trial is slated to compare the safety and effectiveness of the Chocolate Touch balloon with Bard‘s(NYSE:BCR) Lutonix drug-coated balloon catheter. The company said it plans to evaluate non-inferiority and superiority of its DCB over Bard’s device.
Get the full story at our sister site, Drug Delivery Business News.
The post QT Vascular launches pivotal trial for drug-coated peripheral balloon appeared first on MassDevice.

Source: Mass Device - July 31, 2017 Category: Medical Devices Authors: Sarah Faulkner Tags: Clinical Trials Drug-Device Combinations Pharmaceuticals Vascular Wall Street Beat QT Vascular Source Type: news